Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

Kwok, R., Tse, Y.‐K., Wong, G. L.‐H., Ha, Y., Lee, A. U., Ngu, M. C., Chan, H. L.‐Y., Wong, V. W.‐S.·2014·Alimentary Pharmacology & Therapeutics
DOI 10.1111/apt.12569

Cited by (401)

Items 301–400 of 401

  1. Review of correlation methods for evaluating finite element simulations of impact injury risk.
    Qian Wang, Hampton Clay Gabler · 2008 · PubMed
  2. The Diagnostic Evaluation of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Wajahat Zafar Mehal · 2019 · Gastroenterology & Hepatology International Journal
  3. NAFLD therapy and monitoring disease progression
    Pankaj Puri, Vijayalakshmi Aravindan Arun · 2017 · Tropical Gastroenterology
  4. Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass?
    Pedro Funari Pereira, Vinícius von Diemen, Eduardo Neubarth Trindade, Matheus Truccolo Michalczuk, Carlos Thadeu Schmidt Cerski, Anderson Correa Mussi, Debora Figueiro Aldabe, Raphael Nicola Branchi, Pedro Glusman Knijnik, Pietro Waltrick Brum et al. · 2020 · Obesity Surgery
  5. Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels
    Mikkel Breinholt Kjær, Asger Givskov Jørgensen, Søren Fjelstrup, Daniel M. Dupont, Claus Bus, Peter Lykke Eriksen, Karen Louise Thomsen, Jeyanthini Risikesan, Søren Nielsen, Charlotte Wilhelmina Wernberg et al. · 2025 · Biomolecules
  6. Association between serum cytokeratin 18 and N-terminal procollagen III propeptide in patients with biopsy-proven nonalcoholic fatty liver disease*
    Sercan Kaya, Murat Boydak, Mesut Aydın, İbrahim Aras · 2024 · Biotechnic & Histochemistry
  7. Liver Stiffness and Steatosis Measurements with iLivTouch and FibroScan: A Comparative Study
    Mübin Özercan, Zeynep Melekoğlu Ellik, Ayhan Parmaksız, Mesut Gümüşsoy, Serkan Duman, Necati Örmecı · 2024 · The Turkish Journal of Gastroenterology
  8. Steatotic liver disease: what role does alcohol consumption play?
    Gianni Testino, Carmen Fucile, Maurizia Gnocchi, Gian Marco Rosa, Fabio Caputo · 2025 · Minerva Medica
  9. Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
    Yuri Cho · 2024 · Korean Journal of Gastroenterology
  10. Identifying Advanced Fibrosis in NAFLD Using Noninvasive Tests: A Systematic Review of Sequential Algorithms.
    Shaya Noorian, Ankur Patel, Carina Ashkar, Sammy Saab · 2022 · PubMed
  11. Multiclass Classification of Nonalcoholic Steatohepatitis Mouse Models Using Dielectric Properties as Disease Biomarker
    Poulami Samaddar, Keerthy Gopalakrishnan, Priyanka Anvekar, Poushali Samadder, Ivone Cristina Igreja E, Rachel L. Bayer, Sunil Gaddam, Dipankar Mitra, Sayan Kumar Roy, Petra Hirsova et al. · 2022 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  12. Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient Elastography (VCTE)
    Monica Lupșor‐Platon · 2019 · IntechOpen eBooks
  13. Diagnosis and grading of steatotic liver disease via clinical and laboratory data using machine learning
    Behniya Sadeghi, Marzieh Zarrinbal, Hossein Poustchi, Ahmad Sadeghi, Ehsaneh Taheri · 2026 · Scientific Reports
  14. Non-invasive diagnosis of metabolic dysfunction associated steatotic liver disease (MASLD)
    Michael Tseng, Taseen Syed, Mohammad Shadab Siddiqui · 2024 · Elsevier eBooks
  15. Biochemical Biomarkers of NAFLD/NASH
    Ciro Celsa, Grazia Pennisi, Federica Spatola, Aurora Giannetti, Salvatore Petta · 2020 · Springer eBooks
  16. Estimated Prevalence of Advanced Hepatic Fibrosis by Elastography in Patients with Type 2 Diabetes
    Yoshio Sumida · 2020 · Interventions in Obesity & Diabetes
  17. Fibrosis Assessment in Patients with NAFLD
    Victor de Lédinghen · 2020 · Springer eBooks
  18. Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease
    Grace Lai‐Hung Wong, Henry Lik‐Yuen Chan · 2015 · Hepatology International
  19. Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínico
    Iria Cebreiros López, José Antonio Noguera Velasco · 2017 · Revista del Laboratorio Clínico
  20. Nonalcoholic Fatty Liver Disease and Obesity
    Arka De, Ajay Kumar. Duseja · 2021 · Journal of Postgraduate Medicine Education and Research
  21. Ultraschallelastographie
    Ruediger Stephan Goertz · 2015 · Der Radiologe
  22. Transient Elastography in Chronic Liver Diseases
    Gamal El-Sayed Shiha, Nasser Mousa · 2020 · Springer eBooks
  23. Differenzialdiagnose der Fettlebererkrankung
    Jörn Markus Schattenberg, Beate Katharina Straub · 2020 · Die Gastroenterologie
  24. Transient Elastography Research Hotspots and Frontiers in Nonalcoholic Fatty Liver Disease: A Bibliometric Study Using CiteSpace
    Gong Feng, Na He, Qin-Qin Yan, Ke Wang, Rong Li, Xiu-Ting Tan, Man Tian Mi · 2022 · Exploratory Research and Hypothesis in Medicine
  25. Transient elastography for non-invasive assessment of liver fibrosis
    Piyush Manoria · 2025 · Future Health
  26. Elastography in Liver-Transplanted Patients
    Cristina Rigamonti, Carla De Benedittis, Maria Francesca Donato · 2021 · Springer eBooks
  27. Use of Transient Elastography in Assessment of Non Alcoholic Fatty Liver Disease
    N.A. Abd El-Rahman, Ghada Galal, Ramy Abd El Hamid, Sherif Sayed · 2023 · Sohag Medical Journal
  28. The Construction and Performance Evaluation of a Risk Prediction Model for Nonalcoholic Steatohepatitis Based on Serological Markers
    Dongbo Huang, Wanqin Zhang, Ying Fang, Taotao Liu, Da Zhou · 2025 · Gastroenterology Research and Practice
  29. Imaging Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes Mellitus: A Review Article
    Varun Anil Damle, Akarshan Sharma, Brijendra Kumar Srivastava, Viswanathan Mohan · 2025 · Journal of Diabetology
  30. Ultrasound Elastography to Assess Liver Fibrosis: A Systematic Review and Meta-Analysis
    Syed Amir Gilani, Syed Muhammad Yousaf Farooq, Muhammad Moazzam, Asif Hanif, Muhammad Uzair, Maida Iyaz, Yasmeen Niazi · 2026 · Journal of diagnostic medical sonography
  31. Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?
    Benedetta Campana, David Semela, Markus Hermann Heim, Christine Bernsmeier · 2015 · EMJ Hepatology
  32. Extrahepatic complication of nonalcoholic fatty liver disease. Is it a causal association?
    Jiří Ehrmann, Květoslava Aiglová, Drahomíra Vrzalová, Renata Aiglová, M Konečný, Vlastimil Procházka · 2017 · Interní medicína pro praxi
  33. Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD
    Peter Lykke Eriksen, Karen Louise Thomsen, Tea Lund Laursen, Konstantin Kazankov, Sara Heebøll, Henning Grønbæk · 2017 · Current Hepatology Reports
  34. Detection of NAFLD/NASH in the General Population and in Primary Care Clinics
    Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber‐Sagi · 2020 · Springer eBooks
  35. IV. Evaluation of Liver Fibrosis and Steatosis in Non-alcoholic Fatty Liver Disease
    Nobuharu Tamaki, Masayuki Kurosaki · 2020 · Nihon Naika Gakkai Zasshi
  36. Praxisorientierte Strategien für Screening, Diagnostik und Therapie der NAFLD
    Henriette Kreimeyer, Paul Peter Manka, Ali E. Canbay · 2023 · Gastro-News
  37. Immune cell balance as potential biomarker of progressing non-alcoholic fatty liver disease
    Ludmila V. Topchieva, Курбатова Ирина Валерьевна, Ольга Петровна Дуданова, Alina Vasileva, Г. А. Жулай · 2024 · Genes and Cells
  38. The range of diagnostic possibilities of ultrasound liver elastometry in patients with chronic heart failure and diffuse changes in the live
    Alexey Vasilyevich Borsukov, Шестакова Дарья Юрьевна, A. I. Skutar · 2024 · Medical alphabet
  39. Non-Alcoholic Fatty Liver Disease (NAFLD): The Lipid Disease of the Liver and the Effect of Statins
    Mazen Noureddin, David Alexanian, Neil Kaplowitz · 2015 · Springer eBooks
  40. Guía de práctica clínica para la enfermedad hepática grasa no alcohólica Clinical practice guideline for nonalcoholic fatty liver disease
    Oscar Alfredo Beltrán Galvis, Andrés Galindo, Yuly Paulin Mendoza, Geovanny Hernández, Martín Garzón, Jhon Edison Prieto, Rodrigo Pardo, R William Otero, Luis Carlos Sabbagh · 2015
  41. Blood-Based Novel Biomarkers for Nonalcoholic Steatohepatitis
    Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang · 2018 · Biomarkers in Medicine
  42. Non-invasive Assessment of Non-alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography
    Tao Wan, Annalisa Berzigotti · 2020 · Springer eBooks
  43. Non-invasive diagnosis of non-alcoholic fatty liver disease: the available opportunities we have today
    Т. А. Solomentseva · 2019 · Modern Gastroenterology
  44. Editorial: novel association between serum Pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease
    Mhairi Claire Donnelly, Kenneth J. Simpson · 2015 · Alimentary Pharmacology & Therapeutics
  45. Noninvasive diagnosis of nonalcoholic steatohepatitis: Emerging approaches
    Qin Pan, Jian‐Gao Fan · 2018 · Hepatobiliary & pancreatic diseases international
  46. Non‐alcoholic Fatty Liver Disease
    Yaron Rotman, Devika Kapuria · 2020
  47. FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “
    Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono et al. · 2020 · Preprints.org
  48. Screening of nonalcoholic fatty liver disease in patients with coronary heart disease by transient elastography: proceed with caution
    Masato Yoneda, Kento Imajo, Satoru Saito, Atsushi Nakajima · 2014 · Wiener klinische Wochenschrift
  49. Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease
    Dong Shin Kwak, Dae Won Jun, Yong Kyun Cho, Seung Min Lee, Se Hwan Lee, In Sub Jung, Sung Won Lee, Jae-Keun Park, Jung-Hoon Lee, Eun Young Lee et al. · 2014 · Korean Journal of Gastroenterology
  50. Central JSM Gastroenterology and Hepatology
    Monjur Ahmed∥ · 2014
  51. How to best diagnose NAFLD/NASH?
    Vlad Ratziu · 2016
  52. Liver and Spleen
    Emilio Quaia, Anita Spezzacatene, Irene Zorzenon, Valentina Ciaravino, Alessandro Sarno, Giorgia Tedesco, Dirk‐André Clevert, Mirko D’Onofrio · 2016 · Springer eBooks
  53. Ultrasound and liver elastography - tools for detection and quantification of severity in Nonalcoholic Fatty Liver Disease (NAFLD) in general population
    Ioan Sporea · 2017 · Medical Ultrasonography
  54. Dijagnostički sustavni pregled u medicinskoj biokemiji
    Merica Aralica · 2017 · Medicina Fluminensis
  55. Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?
    Emad Hamdy Gad, Yasmin Kamel · 2019 · IntechOpen eBooks
  56. Ultrasound-based liver elastography
    Ioan Sporea, Roxana Șirli · 2019 · Elsevier eBooks
  57. Extracellular Vesicles in Non-alcoholic Fatty Liver Disease: Key Players in Disease Pathogenesis and Promising Biomarker Tools
    Pedro Miguel Rodrigues, Ainhoa Lapitz, André Lopes Simão, Maria Jesus Perugorria, Marco A. Arrese, Rui Eduardo Castro, Jesús M. Bañales · 2020 · Springer eBooks
  58. Diagnostic Algorithm for the Identification of NAFLD in Primary Care
    Helena Cortez‐Pinto · 2020 · Springer eBooks
  59. Non-invasive Diagnostic Approach to NASH: Biological Markers
    Salvatore Petta, Aurora Giannetti · 2020 · Springer eBooks
  60. Сучасні засади діагностики фіброзу печінки у хворих із хронічними дифузними її ураженнями: огляд літератури, опис клінічного випадку
    Y. Leshchuk, Orest Abrahamovych, M. O. Abrahamovych · 2020 · Lviv clinical bulletin
  61. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease
    Hirohito Takeuchi, Katsutoshi Sugimoto, Hisashi Oshiro, Kunio Iwatsuka, Shin Kono, Yu Yoshimasu, Yoshitaka Kasai, Yoshihiro Furuichi, Kentaro Sakamaki, Takao Itoi · 2020 · Choonpa Igaku
  62. Diagnostic methods and pharmacological management of non-alcoholic fatty liver disease – There is still room for improvement
    Chrysoula Boutari, Panagiotis D. Pappas, Κωνσταντίνος Τζιόμαλος, Vasileios Athyros, Asterios I. Karagiannis · 2020 · Journal of Atherosclerosis Prevention and Treatment
  63. Biomarcatori clinici e molecolari per la diagnosi e la stadiazione della NAFLD
    Alessandra Scamporrino, Stefania Di Mauro, Agnese Filippello, Francesco Purrello, Salvatore Piro · 2021 · il Diabete
  64. The Role of Transient Elastography in NAFLD
    Grazia Pennisi, Antonina Giammanco, Salvatore Petta · 2021 · Springer eBooks
  65. A saúde e suas interfaces interdisciplinares multiprofissional
    Silvana Carloto Andrés, Liane Bahú Machado · 2021 · Amplla Editora eBooks
  66. Evaluation of Liver Fibrosis Using Shear Wave Elastography: An Overview
    Dong Ho Lee, Jae Young Lee, Byung Ihn Choi · 2022 · IntechOpen eBooks
  67. Evaluation of the Effectiveness of Methovitane in Comprehensive Treatment of Patients with Non-Alcoholic Steatohepatitis
    И.Н. Скрыпник, А.С. Маслова, Ольга Васильевна Щербак, Наталія Петрівна Приходько · 2022 · Рецепт
  68. Faculty Opinions recommendation of Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.
    Arun Jayant Sanyal · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  69. Faculty Opinions recommendation of Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
    Doug Dieterich, Clara Rodriguez Rivas · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  70. Advances in ultrasound elastography for nonalcoholic fatty liver disease
    Masato Yoneda, Yasushi Honda, Asako Nogami, Kento Imajo, Atsushi Nakajima · 2022 · Choonpa Igaku
  71. A meta-analysis of the diagnostic accuracy of type Ⅳ collagen 7S for the staging of liver fibrosis in NAFLD
    Yasushi Honda, Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Nobuyoshi Kawamura, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo et al. · 2022 · Research Square
  72. Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease
    Ahmed Mohammed Mosaad, Hatem Elalfy, Talaal Amer, Mona Arafa · 2022 · Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis
  73. Prevalencia, severidad y costes asociados al diagnóstico de pacientes con esteatosis hepática metabólica (EHmet)
    Natalia Mora Cuadrado · 2021
  74. DIAGNOSTIC EFFECTIVENESS OF DIFFERENT LIVER ELASTOMETRY METHODS IN PATIENTS WITH HEART FAILURE DEPENDING ON THE STAGE OF THE DISEASE
    Aleksey V. Borsukov, Дорошенко Дмитрий Александрович, A. I. Skutar · 2023 · Acta medica Eurasica
  75. Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for Staging Nonalcoholic Fatty Liver Disease
    Sebastian Zenovia, Cristina Maria Muzica, Mihaela Dimache · 2023 · Springer eBooks
  76. Doença hepática gordurosa não alcoólica em pacientes com diabetes mellitus tipo 2
    Mauy Frujuello Mana · 2021
  77. Steatosis-associated fibrosis estimator (SAFE) score in Asian patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Kunhee Kim, Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Jun Yong Park · 2024 · Research Square
  78. Stem Cells and Extracellular Vesicles for Prevention and Treatment of Liver Fibrosis
    Siti Aishah Sulaiman, Muhammad Nafiz Haidi Adrus, Vicneswarry Dorairaj, Nadiah Abu, Nurul‐Syakima Ab Mutalib, Khairul Najmi Muhammad Nawawi, Nor Azian Abdul Murad · 2024 · Elsevier eBooks
  79. Noninvasive evaluation of liver fibrosis in MASLD—Imaging/elastography based
    Xinrong Zhang, Guanlin Li, Huapeng Lin, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong · 2024 · Elsevier eBooks
  80. Metabolic dysfunction associated fatty liver disease (MAFLD): A review on mechanistic pathways, pathophysiology, and management
    Asheesh K Maurya, Dharamveer, Dipti Srivastava, Himani Awasthi · 2024 · Journal of Pharmacognosy and Phytochemistry
  81. Caffeine mitigates tamoxifen-induced fatty liver in Wistar rats
    Yasin Sezgin, Ejder Saylav Bora, Duygu Burcu Arda, Yiğit Uyanıkgil, Oytun Erbaş · 2024 · Acta Cirúrgica Brasileira
  82. Diagnostic Advances in MASLD
    Paulina Vidal‐Cevallos, Norberto Carlos Chávez-Tapia, Emmanuel A. Tsochatzis · 2024 · Springer eBooks
  83. Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
    Shan Hong, Zi-Fan Hong, Y. Hao, Lei Sun, Hong-Shan Wei · 2025 · Medicine
  84. Metabolic-associated fatty liver disease: Noninvasive diagnosis and assessment of liver fibrosis
    O. O. Karshina, Ibragim S. Sabirov · 2025 · Meditsinskiy sovet = Medical Council
  85. Possibilities and disadvantages of modern non-invasive methods of diagnostics of metabolic-associated fatty liver disease
    O. O. Karshina, Ibragim S. Sabirov · 2024 · Экспериментальная и клиническая гастроэнтерология
  86. Foie métabolique
    Antonio Saviano, Lawrence Serfaty · 2025 · EMC - Hépatologie
  87. Post-Bariatric Surgery Liver Injury Assessment Using Circulating Caspase-Cleaved Keratin 18
    Wiktoria Suchy, Adriana Stelmach, Maria Szymonowicz, Krzysztof Safranow · 2023 · Bulletin of pioneering researches of medical and clinical science
  88. Integrated analysis of RNA-binding proteins in MAFLD: mechanistic insights and diagnostic biomarker potential via alternative splicing
    Panpan Xia, Xiaopeng Li, Jie Peng, Kaibo Hu, Jitao Ling, Yuting Wu, Jianqi Liang, Yunkun Liu, Yan Xiong, Jianping Liu et al. · 2025 · Journal of Bioenergetics and Biomembranes
  89. Additional file 6 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  90. Additional file 5 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  91. Additional file 1 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  92. Additional file 3 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  93. Additional file 7 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  94. Additional file 2 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  95. Additional file 4 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
  96. Steatosis-Associated Fibrosis Estimator Score in Asian Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kunhee Kim, Hye Won Lee, Jae Seung Lee, Mi Na Kim, Jun Yong Park · 2025 · Yonsei Medical Journal
  97. Cytokeratin 18 as a new marker for nonalcoholic fatty liver disease diagnosis in Down syndrome children
    Eman A. Sakr, Hadil Mohamed Aboelenin, Ahmed ElSayed Wageeh, Nermin Ahmed, Ashraf A. Elsharkawy, Mohammad Alhaggar · 2026 · CHILD`S HEALTH
  98. Caractérisation de nouveaux biomarqueurs et développement d’un test rapide pour l’amélioration du diagnostic des maladies hépatiques
    Arnaud Chalin · 2018
  99. Étude de deux acteurs dans le développement des complications hépatiques liées à l’obésité : la vitamine D et FNDC5/Irisine
    Clémence M. Canivet · 2019
  100. Effect of cholecystectomy on liver fat and fibrosis in metabolic dysfunction-associated steatotic liver disease patients
    Khellaf Amalou, Nassila Belal, Abdelghani Tibouk, Yasmine Ghedada, Ryma Rekab, Sabrina Fadel, Nabil Debzi, Abderezak Bousloub · 2026 · World Journal of Gastrointestinal Pharmacology and Therapeutics